出品 | 华博商业评论当年轻人的“朋克养生”频频成为热门话题时，保健品似乎却卖不动了。近年来，保健品行业上市公司业绩纷纷下滑，就连“保健品一哥”汤臣倍健的业绩也意外出现了暴跌。2024年，汤臣倍健实现营业收入68.38亿元，同比下降27.30%；归属于上市公司股东的净利润6.53亿元，同比下降62.62%；今年一季度，汤臣倍健的业绩依旧不见回暖，营业收入为17.92亿元，同比下滑32.29%，...
Source Link出品 | 华博商业评论当年轻人的“朋克养生”频频成为热门话题时，保健品似乎却卖不动了。近年来，保健品行业上市公司业绩纷纷下滑，就连“保健品一哥”汤臣倍健的业绩也意外出现了暴跌。2024年，汤臣倍健实现营业收入68.38亿元，同比下降27.30%；归属于上市公司股东的净利润6.53亿元，同比下降62.62%；今年一季度，汤臣倍健的业绩依旧不见回暖，营业收入为17.92亿元，同比下滑32.29%，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.